Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

New research reveals positive therapies and methods for treating prostate cancer.

Mitka M.

JAMA. 2012 Aug 1;308(5):441-2. doi: 10.1001/jama.2012.7960. No abstract available.

PMID:
22851092
2.

Radiation plus hormone therapy reduces prostate cancer mortality.

[No authors listed]

Cancer Discov. 2014 Apr;4(4):OF1. doi: 10.1158/2159-8290.CD-NB2014-026. Epub 2014 Feb 20. No abstract available.

3.

[Treatment of prostate cancer].

Romics I.

Orv Hetil. 2010 Apr 4;151(14):580-3. doi: 10.1556/OH.2010.28810. Hungarian. No abstract available.

PMID:
20332076
4.

Current evidence for the role of combined androgen suppression and radiation in the treatment of adenocarcinoma of the prostate.

DeWeese TL, Song DY.

Urology. 2000 Feb;55(2):169-74. Review. No abstract available.

PMID:
10688072
5.

[Early versus late hormonal treatment in advanced prostate cancer].

Allepuz Losa C, Gil Martínez P, Gil Sanz MJ, Rioja Sanz LA.

Actas Urol Esp. 1999 Jul-Aug;23(7):557-64. Review. Spanish. No abstract available.

PMID:
10488608
6.

[The role of systemic radiotherapy in the combined treatment for hormone-resistant prostate cancer].

Solodky VA, Pavlov AY, Panshin GA, Gafanov RA, Fastovets SV, Isaev TK.

Vopr Onkol. 2015;61(1):31-3. Russian.

PMID:
26016142
7.

[Significance of neoadjuvant therapy for prostate cancer].

Okada K, Hachiya T.

Nihon Hinyokika Gakkai Zasshi. 1997 Sep;88(9):769-77. Review. Japanese. No abstract available.

8.

Critical evaluation of hormonal therapy for carcinoma of the prostate.

Chodak GW, Keane T, Klotz L; Hormone Therapy Study Group.

Urology. 2002 Aug;60(2):201-8. Review. No abstract available.

PMID:
12137810
9.

Combined hormone therapy and radiation therapy for locally advanced prostate cancer.

Bolla M, Laramas M; Association of Radiotherapy and Oncology of the Mediterranean arEa (AROME).

Crit Rev Oncol Hematol. 2012 Dec;84 Suppl 1:e30-4. doi: 10.1016/j.critrevonc.2010.11.003. Epub 2010 Dec 8. Review.

PMID:
21144766
10.

Combined androgen blockade in prostate cancer: meta-analyses and associated issues.

Klotz L.

BJU Int. 2001 Jun;87(9):806-13. No abstract available.

11.

Case records of the Massachusetts General Hospital. Case 16-2011. A 67-year-old man with recurrent prostate cancer.

Smith MR, Zietman AL, Finkelstein JS, Wu CL.

N Engl J Med. 2011 May 26;364(21):2044-51. doi: 10.1056/NEJMcpc1011323. No abstract available.

PMID:
21612474
12.

RE: Androgen Deprivation With or Without Radiation Therapy for Clinically Node-Positive Prostate Cancer.

Briganti A, Gandaglia G, Fossati N, Moschini M, Montorsi F.

J Natl Cancer Inst. 2015 Jul 23;107(9). pii: djv200. doi: 10.1093/jnci/djv200. Print 2015 Sep. No abstract available.

13.
14.

Androgen suppression plus radiation for prostate cancer.

Millar J.

JAMA. 2004 Dec 1;292(21):2581-2; author reply 2582. No abstract available.

PMID:
15572714
15.

Words of Wisdom. Re: Androgen Deprivation With or Without Radiation Therapy for Clinically Node-Positive Prostate Cancer.

Isbarn H.

Eur Urol. 2016 Feb;69(2):372-3. doi: 10.1016/j.eururo.2015.10.062. No abstract available.

PMID:
26758519
16.

Combination of somatostatin analogues and dexamethasone (anti-survival-factor concept) with luteinizing hormone-releasing hormone in androgen ablation-refractory prostate cancer with bone metastasis.

Koutsilieris M, Dimopoulos T, Milathianakis C, Bogdanos J, Karamanolakis D, Pissimissis N, Halapas A, Lembessis P, Papaioannou A, Sourla A.

BJU Int. 2007 Jul;100 Suppl 2:60-2. Review. No abstract available.

17.

Multimodality therapy: bone-targeted radioisotope therapy of prostate cancer.

Tu SM, Lin SH, Podoloff DA, Logothetis CJ.

Clin Adv Hematol Oncol. 2010 May;8(5):341-51. Review.

18.

Role of radiation and androgen deprivation therapy for advanced prostate cancer.

Jani AB, Rossi PJ.

Curr Probl Cancer. 2015 Jan-Feb;39(1):41-7. doi: 10.1016/j.currproblcancer.2014.11.007. Epub 2014 Nov 25. Review. No abstract available.

PMID:
25554467
19.

[Diagnosis and treatment of early prostate cancer].

Kaprin AD, Khalil Farzat M, Gafanov RA, Kostin AA.

Vopr Onkol. 2009;55(3):382-5. Russian. No abstract available.

PMID:
19670743
20.

Node-positive prostatic carcinoma.

Lawton C.

Int J Radiat Oncol Biol Phys. 1997 Oct 1;39(3):671-2. No abstract available.

PMID:
9336148

Supplemental Content

Support Center